Market Tracker

01/20 5:16pm ET

Apricus Biosciences Inc (NASDAQ:APRI)

2.72
Delayed Data
As of Jan 20
 +0.33 / +13.81%
Today’s Change
1.10
Today|||52-Week Range
15.40
+109.23%
Year-to-Date

Today’s Trading

Previous close2.39
Today’s open2.38
Day’s range2.10 - 2.83
Volume2,489,408
Average volume (3 months)809,723
Market cap$21.0M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+30.45%
Earnings growth (this year)+61.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.74%
P/E ratioNM
Price/Sales10.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc-0.01-1.81%
INNLInnocoll Holdings PL...+0.01+1.23%
BLPHBellerophon Therapeu...+0.04+5.51%
TNXPTonix Pharmaceutical...-0.01-1.16%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$4.8M
Annual profit (last year)-$19.0M
Net profit margin-393.12%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts